Reelin, a marker of stress resilience in depression and psychosis

S. Hossein Fatemi

doi:10.1038/npp.2011.169

Reelin, a marker of stress resilience in depression and psychosis

S. Hossein Fatemi

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Comment/debate › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	2371-2372
Number of pages	2
Journal	Neuropsychopharmacology
Volume	36
Issue number	12
DOIs	https://doi.org/10.1038/npp.2011.169
State	Published - Nov 2011

Bibliographical note

Funding Information:
This work was supported by NIH grants (5R01HD052074-05 and 5R01MH086000-01A2). Dr SH Fatemi has received patents for use of Reelin as a diagnostic marker for psychiatric disorders. He has not derived any financial gains from these patents. Dr SH Fatemi acknowledges the critical review of this commentary by T Folsom, R Kneeland, S Liesch, and Dr M Karkhane Yousefi.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1038/npp.2011.169

Find It

Find It at U of M Libraries

Cite this

@article{4d8bc7679cec41a7aaca124363ff2bb2,

title = "Reelin, a marker of stress resilience in depression and psychosis",

author = "Fatemi, {S. Hossein}",

note = "Funding Information: This work was supported by NIH grants (5R01HD052074-05 and 5R01MH086000-01A2). Dr SH Fatemi has received patents for use of Reelin as a diagnostic marker for psychiatric disorders. He has not derived any financial gains from these patents. Dr SH Fatemi acknowledges the critical review of this commentary by T Folsom, R Kneeland, S Liesch, and Dr M Karkhane Yousefi.",

year = "2011",

month = nov,

doi = "10.1038/npp.2011.169",

language = "English (US)",

volume = "36",

pages = "2371--2372",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Reelin, a marker of stress resilience in depression and psychosis

AU - Fatemi, S. Hossein

N1 - Funding Information: This work was supported by NIH grants (5R01HD052074-05 and 5R01MH086000-01A2). Dr SH Fatemi has received patents for use of Reelin as a diagnostic marker for psychiatric disorders. He has not derived any financial gains from these patents. Dr SH Fatemi acknowledges the critical review of this commentary by T Folsom, R Kneeland, S Liesch, and Dr M Karkhane Yousefi.

PY - 2011/11

Y1 - 2011/11

UR - http://www.scopus.com/inward/record.url?scp=80054729732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054729732&partnerID=8YFLogxK

U2 - 10.1038/npp.2011.169

DO - 10.1038/npp.2011.169

M3 - Comment/debate

C2 - 21997708

AN - SCOPUS:80054729732

SN - 0893-133X

VL - 36

SP - 2371

EP - 2372

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 12

ER -

Reelin, a marker of stress resilience in depression and psychosis

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this